Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2006
09/20/2006EP0819250B1 Multiparameter cell separation using releasable colloidal magnetic particles
09/20/2006CN2819220Y Magnetic separator of enzyme target board
09/20/2006CN2818484Y Cell tractive tension controller
09/20/2006CN2817739Y Miniature atraumatic PH-value monitor of bronchus milieu interieur
09/20/2006CN1836167A Diagnostic composition for diabetes type-2 and impaired glucose tolerance, and methods of use
09/20/2006CN1836166A Method for detecting neoplastic disorders in a solubilized body sample
09/20/2006CN1836165A Method for detecting low levels of a fusion protein
09/20/2006CN1836164A A method for the identification of IRS protein kinase inhibitors or agonists
09/20/2006CN1836163A Method for measuring substance having affinity
09/20/2006CN1836162A Method for producing bioassay substrate by superposing two substrates one on another and bioassay substrate
09/20/2006CN1836161A 电化学传感器 Electrochemical sensors
09/20/2006CN1836160A Method and apparatus for analysing particulates
09/20/2006CN1836159A Method of making a biosensor
09/20/2006CN1836157A Moveable transparent barrier for x-ray analysis of a pressurized sample
09/20/2006CN1836154A A method of compensating for a measuring error and an electronic arrangement to this end
09/20/2006CN1836148A Method of determining a dimension of a sample of a construction material and associated apparatus
09/20/2006CN1836049A Methods for detecting aneuploidy using microparticle multiplex detection
09/20/2006CN1835974A Antibodies specific for sclerostin and methods for increasing bone mineralization
09/20/2006CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein
09/20/2006CN1835968A Compositions and methods for increasing bone mineralization
09/20/2006CN1835768A Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies
09/20/2006CN1835763A CCN1 compositions and methods
09/20/2006CN1835691A Indicator device
09/20/2006CN1834659A Sample analyzer and sample analyzing method
09/20/2006CN1834658A Pretreatment system of testing application and sample's collection
09/20/2006CN1834655A Method of detecting etiology by tacteriophage immunity PCR
09/20/2006CN1834654A Kit for diagnosing high triglyceride
09/20/2006CN1834653A Method of detecting cancer cells by utilizing biomagnetic piezoelectric sensing array
09/20/2006CN1834652A Immunity chromatography test paper for detecting Brucella and its prepn. method
09/20/2006CN1834651A Immunity chromatography test paper for detecting farcinia Boeck Hold's bacteria infection and prepn. method thereof
09/20/2006CN1834650A Immunity chromatography test paper for detecting farcina Boeck Hold's bacteria infection and prepn. method thereof
09/20/2006CN1834649A Immunity chromatography test paper for detecting farcinia Boeck Hold's bacteria infection and prepn. method therof
09/20/2006CN1834648A Detection for improving antibody to antagonize virus and method and kit for early detection of serum negative peronality
09/20/2006CN1834647A Detection for inproving antibody to antagonize HIV and HCV and method and kit for early detection of serum negative personality
09/20/2006CN1834646A Method of monitoring environment As pollution by utilizing earthworm
09/20/2006CN1834645A Biomarking monitoring method of environment pollution caused by As
09/20/2006CN1834644A Reagent for detecting beer series taste
09/20/2006CN1834637A Detection method of electronic sensor
09/20/2006CN1834636A Extracellular potential measuring device and method for fabricating the same
09/20/2006CN1834634A Water content of lub oil analyzer for towboat rudder propeller
09/20/2006CN1834622A Detector and method for liquid sampler
09/20/2006CN1834612A Multifunction dilutent for blood cell analyzer and prepn. method
09/20/2006CN1834611A Cyanogen-less hemolysin for blood cell analyzer and prepn. method
09/20/2006CN1834244A Full length polynucleotide sequence of new allelic gene A*110104 of encoded human leucocyte antigen A*11 and uses thereof
09/20/2006CN1833783A Solution striping system
09/20/2006CN1833724A Cancer treatment through suction effect T-cell and loss regulating T-cell
09/20/2006CN1276258C Biological sample structure hydrogen-deuterium substitution verification and deuterium percentage content determining method
09/20/2006CN1276257C T cell immune state detecting method for hepatitis B patient
09/20/2006CN1276256C Methods of manufacturing reagent test strips and application of reagent test strips
09/20/2006CN1276255C Nephropathy examining reagent, means of examining nephropathy and its components
09/20/2006CN1276254C Testing method for filtering experimental compound and reagent box
09/20/2006CN1276252C Method for measurement of nucleated red blood cells
09/20/2006CN1276249C Non-invasive in-vivo tissue classification using near-infrared measurements
09/20/2006CN1276248C Bacteriotoxin quantitive detecting method-dynamic end-point method
09/19/2006US7110890 Auto-analysis framework for sequence evaluation
09/19/2006US7110888 Method for determining a shape space for a set of molecules using minimal metric distances
09/19/2006US7110887 Residual chlorine meter
09/19/2006US7110884 Methods in the engineering design and construction of earthen fills
09/19/2006US7110808 Method of optimizing radiosurgery and radiotherapy with metalloporphyrins
09/19/2006US7110585 Nanoparticle imaging system and method
09/19/2006US7110584 Cell lineage extracting method
09/19/2006US7110572 Animal carcase analysis
09/19/2006US7110345 Multiple data layer optical discs for detecting analytes
09/19/2006US7110094 Apparatus and method for carrying out analysis of samples using radiation detector output ratios
09/19/2006US7109842 Robust fluid flow and property microsensor made of optimal material
09/19/2006US7109729 Method for analysis of a working fluid using impedance spectroscopy
09/19/2006US7109377 Synthesis of combinatorial libraries of compounds reminiscent of natural products
09/19/2006US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands
09/19/2006US7109314 Fluorescent nucleotides
09/19/2006US7109310 Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs
09/19/2006US7109309 Peptide fructose and protein conjugate with the same
09/19/2006US7109301 Tenascin-C isoform as marker for neoplasias
09/19/2006US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems
09/19/2006US7109294 Identifying compounds which alter sensitivity of a microorganism to microbicidal agents; drug screening
09/19/2006US7109293 System for detecting protease
09/19/2006US7109044 Determining the concentration of albumin in a urine sample of a test subject to be normal; determining a concentration of human lipocalin-type prostaglandin D synthase (L-PGDS) then in a urine sample taken from the same test subject; comparing
09/19/2006US7109043 Fluorescent probe for magnesium ion determination
09/19/2006US7109042 Assays
09/19/2006US7109041 Solubilzing and supporting G protein coupled receptors on beads and micelles for use in microtiter plates and cytometry; drug screening
09/19/2006US7109040 Modular isotope coding approach to proteomic analysis
09/19/2006US7109039 Immersing a sample taken from semiconductor device fabrication equipment in chemical formulation; dissolving the sample; cooling dissolved sample; diluting the dissolved sample with deionized water and analyzing the diluted sample using Atomic Absorption Spectrometer or by Atomic Emission spectroscopy
09/19/2006US7109038 Occult blood detection in biological samples by laser desorption and matrix-assisted laser desorption/ionization mass spectrometry for biomedical applications
09/19/2006US7109037 Water-based resist stripping liquid management apparatus and water-based resist stripping liquid management method
09/19/2006US7109036 Hematology reference control containing an immature granulocyte component
09/19/2006US7109035 A kit comprising synthetic urine and a method of using the same, wherein the synthetic urine composition has characteristics of human urine
09/19/2006US7109030 Anticarcinogenic, antiproliferative agents; drug screening, receptor binding assay
09/19/2006US7109028 Methods of isolating hepatic progenitors
09/19/2006US7109023 Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
09/19/2006US7109003 Methods for expressing and recovering human monoclonal antibodies to CTLA-4
09/19/2006US7109002 obtained by recombinant expression of DNA of human herpes virus type 8, and which may be used in diagnosis and treatment of human diseases such as kaposi sarcoma, Castleman's disease, multiple myeloma, kidney cell carcinoma, mesangial proliferative glomerulonephritis or B cell lymphoma
09/19/2006US7108996 Using enhanced luciferase as reporter molecule to monitor molecular events in biology, biochemistry, immunology and cell biology
09/19/2006US7108995 Small peptides having apoptotic activities and their applications
09/19/2006US7108994 Identifying a compound that modulates phosphotyrosine phosphatase activity of a polypeptide by incuabating togetjer and measuring activity of enzyme
09/19/2006US7108993 Obtaining accurate determination of analyte concentration in fluid test sample containing heterophilic antibodies with non-specific binding associatons; improving immunoasay sensitivity
09/19/2006US7108992 Detecting activated kinase in sample; obtain sample containing kinase, determine phosphorylation state of serine, phosphorylation of preferential serine indicates active state
09/19/2006US7108991 Receptors whose endogenous ligand has not been identified (orphan)
09/19/2006US7108990 Chemokine receptor
09/19/2006US7108989 Therapy
09/19/2006US7108988 Methods of identifying agents for inhibiting lentivirus replication
09/19/2006US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors